Knotts, C.; Park, H.; Sherry, C.; Blodgett, R.; Lewis, C.; Omstead, A.; Xiao, K.; LaFramboise, W.; Bartlett, D.L.; Dadgar, N.;
et al. Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival. Cancers 2025, 17, 542.
https://doi.org/10.3390/cancers17030542
AMA Style
Knotts C, Park H, Sherry C, Blodgett R, Lewis C, Omstead A, Xiao K, LaFramboise W, Bartlett DL, Dadgar N,
et al. Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival. Cancers. 2025; 17(3):542.
https://doi.org/10.3390/cancers17030542
Chicago/Turabian Style
Knotts, Chelsea, Hyun Park, Christopher Sherry, Rose Blodgett, Catherine Lewis, Ashten Omstead, Kunhong Xiao, William LaFramboise, David L. Bartlett, Neda Dadgar,
and et al. 2025. "Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival" Cancers 17, no. 3: 542.
https://doi.org/10.3390/cancers17030542
APA Style
Knotts, C., Park, H., Sherry, C., Blodgett, R., Lewis, C., Omstead, A., Xiao, K., LaFramboise, W., Bartlett, D. L., Dadgar, N., Goel, A., Zaidi, A. H., & Wagner, P. L.
(2025). Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival. Cancers, 17(3), 542.
https://doi.org/10.3390/cancers17030542
